Scripta Insights, an organization that develops pharmacy navigation options for self-insured employers, well being plans and members, is getting into right into a strategic partnership with RxSaveCard, which presents pharmacy profit cost-containment and fee choices.
The partnership goals to assist self-insured employers fulfill their fiduciary obligations and scale back prescription drug prices by offering members with entry to reasonably priced remedy choices, whether or not coated by their well being plan or through cash-pay alternate options.
In a press release, Scripta defined that it’ll combine RxSaveCard into its Rx Navigation platform, which the corporate says will profit shoppers who’ve the absolutely custom-made answer in place.
For members, it goals to assist them save on high-cost specialty medicine, together with GLP-1s.
For self-insured employers, the aim is to cut back plan spend by avoiding conventional pharmacy profit supervisor (PBM) markups.
Moreover, Scripta will steer members to essentially the most cost-effective remedy choices obtainable.
That would imply a coated drug by their well being plan, changing to a cheaper different or utilizing a money pay supply like RxSaveCard.
Scripta acknowledged that the RxSaveCard additionally permits plan sponsors to supply low- or no-cost medicines to members with out requiring a swap to a brand new PBM.
Moreover, employers fund a pay as you go digital card each month that covers all or a part of the focused drug prices.
Members will have the ability to use the cardboard at over 65,000 pharmacies, together with Mark Cuban Value Plus Medicine and Lilly Direct, with the employer-funded quantity utilized robotically at checkout.
In keeping with Scripta, members can have the flexibility to seek for RxSaveCard discounted costs and pharmacy alternate options and entry their playing cards immediately within the Scripta member app. Scripta may even present shoppers with detailed reporting on their financial savings.
“RxSaveCard shares our dedication to innovating the standard pharmacy advantages mannequin and placing sufferers again in command of their prescription decisions,” Eric Levin, CEO of Scripta Insights, mentioned in a press release.
“By integrating RxSaveCard’s nationwide low cost community into our Scripta Financial savings Mapper, we’re making it even simpler for members to check all their choices, together with new money pay alternate options, and lower your expenses on their prescriptions.”
THE LARGER TREND
In Could, Scripta Insights launched its GLP-1 Navigator, a device within the Scripta member app that gives sufferers with details about GLP-1 medicines in a centralized information.
Up to date weekly, Scripta’s GLP-1 Navigator helps members perceive their choices and the trade-offs, no matter whether or not their plan covers GLP-1s.
In 2024, Scripta Insights introduced it raised $17 million in Sequence B funding, led by Aquiline, bringing its whole funding to $42 million on the time.
Contour Enterprise Companions, Eastside Companions and ReMY Buyers participated within the spherical.
In 2023, Scripta Insights collaborated with Mark Cuban Value Plus Drug Firm.
In a press release, the corporate mentioned the connection furthered Scripta’s mission to get members the best meds at the perfect value.
In 2024, RxSaveCard raised $1.7 million in seed funding to drive development and develop client entry to reasonably priced medicines.
In keeping with BusinessWire, the spherical was led by Distributed Ventures, with participation from trade insiders.
